145 related articles for article (PubMed ID: 10936386)
1. Acute liver failure attenuates hyperacute xenograft rejection.
Stockmann HB; Hiemstra CA; Meijer R; Marquet RL; IJzermans JN
Transplant Proc; 2000 Aug; 32(5):1114-5. PubMed ID: 10936386
[No Abstract] [Full Text] [Related]
2. Induction of accommodation prevents hyperacute rejection.
Vriens PW; Bouwman E; Scheringa M
Transplant Proc; 1997; 29(1-2):597-8. PubMed ID: 9123147
[No Abstract] [Full Text] [Related]
3. Brequinar sodium and liver hemoperfusion in xenotransplantation.
Chastanet S; Cursio R; Gugenheim J; Baldini E; Chevallier A; Damais A; Charpentier B; Mouiel J
Transplant Proc; 1998 Aug; 30(5):2244-5. PubMed ID: 9723457
[No Abstract] [Full Text] [Related]
4. Fab fragments from intravenous immunoglobulin prevent hyperacute rejection in the guinea pig-to-rat combination without reducing hemolytic complement activity in rat serum.
Urbani L; Cardoso J; Soubrane O; Houssin D; Gautreau C
Transplant Proc; 2000 Dec; 32(8):2707-9. PubMed ID: 11134770
[No Abstract] [Full Text] [Related]
5. Cellular immune reaction in hyperacute rejection.
Wada S; Ochikubo H; Sugawara Y; Sueda T; Fujii K; Kajihara H; Matsuura Y
Transplant Proc; 1998 Nov; 30(7):3818-20. PubMed ID: 9838672
[No Abstract] [Full Text] [Related]
6. Soluble complement receptor type 1 and antithrombin-III combination therapy prolongs xenograft survival: the role of thrombin and prostacyclin in hyperacute rejection.
Fujiwara I; Nakajima H; Akioka K; Matsuda T; Oka T
Transplant Proc; 1997; 29(1-2):935-7. PubMed ID: 9123594
[No Abstract] [Full Text] [Related]
7. Normal human polyclonal immunoglobulins for intravenous use significantly delay hyperacute xenograft rejection.
Latremouille C; Haeffner-Cavaillon N; Goussef N; Mandet C; Hinglais N; Bruneval P; Bariety J; Carpentier A; Glotz D
Transplant Proc; 1994 Jun; 26(3):1285. PubMed ID: 8029910
[No Abstract] [Full Text] [Related]
8. White blood cells and platelets are integral to the hyperacute rejection of the pig heart by human blood.
Young VK; Kaspar-König W; Tew DN; Wallwork J; White DJ; Pierson RN
Transplant Proc; 1995 Feb; 27(1):272-3. PubMed ID: 7879000
[No Abstract] [Full Text] [Related]
9. CD39/vascular ATP diphosphohydrolase modulates xenograft survival.
Imai M; Takigami K; Guckelberger O; Lin Y; Sevigny J; Kaczmarek E; Goepfert C; Enjyoji K; Bach FH; Rosenberg RD; Robson SC
Transplant Proc; 2000 Aug; 32(5):969. PubMed ID: 10936301
[No Abstract] [Full Text] [Related]
10. Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival.
Stevens RB; Wang YL; Kaji H; Lloveras J; Dalmasso A; Bach FH; Rubinstein P; Sutherland DE; Platt JL
Transplant Proc; 1993 Feb; 25(1 Pt 1):382. PubMed ID: 8438344
[No Abstract] [Full Text] [Related]
11. Prolongation of xenograft survival by soluble complement receptor type 1 and antithrombin-III combination therapy.
Fujiwara I; Nakajima H; Arakawa K; Akioka K; Takeshita K; Oka T
Transplant Proc; 1996 Apr; 28(2):685-6. PubMed ID: 8623345
[No Abstract] [Full Text] [Related]
12. Retinoic acid inhibits expression of E-selectin in endothelial cells and prolongs discordant xenograft survival.
Blakely ML; Van der Werf WJ; Stuhlmeier K; Dalmasso AP; Winkler H; Bach FH
Transplant Proc; 1994 Jun; 26(3):1176. PubMed ID: 7518108
[No Abstract] [Full Text] [Related]
13. The anticoagulant effect of antithrombin III on hyperacute xenograft rejection.
Takeshita K; Arakawa K; Okamoto M; Akioka K; Fujiwara I; Kobayashi K; Imanishi J; Oka T
Transplant Proc; 1996 Apr; 28(2):631-2. PubMed ID: 8623314
[No Abstract] [Full Text] [Related]
14. Additive effect of cyclosporine on guinea pig heart graft survival in complement-depleted rats.
Scheringa M; Bouwman E; Schraa EO; Buchner B; de Bruin RW; IJzermans JN; Marquet RL
Transplant Proc; 1994 Apr; 26(2):1022-3. PubMed ID: 8171455
[No Abstract] [Full Text] [Related]
15. Effects of various routes of donor-specific antigen administration on graft survival in a model of discordant heart xenotransplantation.
Akpinar E; Arikan U; Bilgin N
Transplant Proc; 1998 May; 30(3):809-11. PubMed ID: 9595108
[No Abstract] [Full Text] [Related]
16. Correlation between graft mass and graft survival time in a discordant cardiac xenotransplantation model: a preliminary report.
Akpinar E; Arikan U; Bilgin N
Transplant Proc; 1998 May; 30(3):812-3. PubMed ID: 9595109
[No Abstract] [Full Text] [Related]
17. Porcine heart xenograft function and hyperacute rejection: the role of thrombin inhibition.
Uchita S; Thein E; Huber H; Wimmer C; Kur F; Brenner P; Hammer C
Transplant Proc; 2001; 33(1-2):729-31. PubMed ID: 11267043
[No Abstract] [Full Text] [Related]
18. Beneficial effect of xenogeneic fetal liver fragment transplantation into a heterotopic subcutaneous omentum in acute liver failure in rats.
Shimura T; Takebe K; Munkhbat B; Hagihara M; Tsuji K
Transplant Proc; 1994 Jun; 26(3):1330. PubMed ID: 8029928
[No Abstract] [Full Text] [Related]
19. Paradoxical effects of xenografting in the nude rat: effect of splenectomy on aberrant graft rejection.
Araneda D; Carobbi A; Thomas J; Thomas F
Transplant Proc; 1992 Apr; 24(2):495-6. PubMed ID: 1566402
[No Abstract] [Full Text] [Related]
20. Delayed xenograft rejection in complement-depleted T-cell-deficient rat recipients of guinea pig cardiac grafts.
Candinas D; Bach FH; Hancock WW
Transplant Proc; 1996 Apr; 28(2):678. PubMed ID: 8623340
[No Abstract] [Full Text] [Related]
[Next] [New Search]
